|
|
||||||||
1 Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool L3 2ET; Departments of 3 Biochemistry and Molecular Biology and 4 Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom; and 2 Michael Reese Hospital and Medical Center, Chicago, Illinois 60616-3990
Myocyte-specific necrosis in
the heart and soleus muscle of adult male Wistar rats was investigated
in response to a single subcutaneous injection of the anabolic
2-adrenergic receptor agonist clenbuterol. Necrosis was
immunohistochemically detected by administration of a myosin antibody
1 h before the clenbuterol challenge and quantified by using image
analysis. Clenbuterol-induced myocyte necrosis occurred against a
background of zero damage in control muscles. In the heart, the
clenbuterol-induced necrosis was not uniform, being more abundant in
the left subendocardium and peaking 2.4 mm from the apex. After
position (2.4 mm from the apex), dose (5 mg clenbuterol/kg), and
sampling time (12 h) were optimized, maximum cardiomyocyte necrosis was
found to be 1.0 ± 0.2%. In response to the same parameters
(i.e., 5 mg of clenbuterol and sampled at 12 h), skeletal myocyte
necrosis was 4.4 ± 0.8% in the soleus. These data show
significant myocyte-specific necrosis in the heart and skeletal muscle
of the rat. Such irreversible damage in the heart suggests that
clenbuterol may be damaging to long-term health.
anabolic adrenergic agonist; cardiomyocytes; sympathomimetic; necrosis; immunohistochemistry;
-adrenergic antagonists
This article has been cited by other articles:
![]() |
G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Birks, P. D. Tansley, J. Hardy, R. S. George, C. T. Bowles, M. Burke, N. R. Banner, A. Khaghani, and M. H. Yacoub Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure N. Engl. J. Med., November 2, 2006; 355(18): 1873 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Burniston, L.-B. Tan, and D. F. Goldspink Relative myotoxic and haemodynamic effects of the {beta}-agonists fenoterol and clenbuterol measured in conscious unrestrained rats Exp Physiol, November 1, 2006; 91(6): 1041 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Mikkelsen, H. Gissel, A. Fredsted, and T. Clausen Excitation-induced cell damage and {beta}2-adrenoceptor agonist stimulated force recovery in rat skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R265 - R272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G Burniston, A. Saini, L.-B. Tan, and D. F Goldspink Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat Exp Physiol, September 1, 2005; 90(5): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch Chronic {beta}-agonist administration affects cardiac function of adult but not old rats, independent of {beta}-adrenoceptor density Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H344 - H349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Burniston, L.-B. Tan, and D. F. Goldspink {beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Harcourt, A. G. Holmes, P. Gregorevic, J. D. Schertzer, N. Stupka, D. R. Plant, and G. S. Lynch Interleukin-15 Administration Improves Diaphragm Muscle Pathology and Function in Dystrophic mdx Mice Am. J. Pathol., April 1, 2005; 166(4): 1131 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. R. Soppa, R. T. Smolenski, N. Latif, A. H. Y. Yuen, A. Malik, J. Karbowska, Z. Kochan, C. M. N. Terracciano, and M. H. Yacoub Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1468 - H1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Busquets, M. T. Figueras, G. Fuster, V. Almendro, R. Moore-Carrasco, E. Ametller, J. M. Argiles, and F. J. Lopez-Soriano Anticachectic Effects of Formoterol: A Drug for Potential Treatment of Muscle Wasting Cancer Res., September 15, 2004; 64(18): 6725 - 6731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Goldspink, J. G. Burniston, G. M. Ellison, W. A. Clark, and L.-B. Tan Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol, July 1, 2004; 89(4): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |